Ovid Therapeutics
OVID
OVID
82 hedge funds and large institutions have $44.4M invested in Ovid Therapeutics in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
19% less capital invested
Capital invested by funds: $54.7M → $44.4M (-$10.3M)
Holders
82
Holding in Top 10
1
Calls
$4K
Puts
–
Top Buyers
| 1 | +$934K | |
| 2 | +$934K | |
| 3 | +$294K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$272K |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$86.6K |
Top Sellers
| 1 | -$860K | |
| 2 | -$368K | |
| 3 | -$360K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$127K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$108K |